These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26821285)

  • 21. [Hereditary angioedema. Treatment of acute attacks in Argentina].
    Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
    Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
    Tallroth GA
    Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approach in prophylactic treatment of a challenged HAE patient.
    Jordal O; Bygum A
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30837234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients perception of self-administrated medication in the treatment of hereditary angioedema.
    Wang A; Fouche A; Craig TJ
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):120-5. PubMed ID: 26118352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
    Nzeako UC; Longhurst HJ
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
    Wasserman RL; Levy RJ; Bewtra AK; Hurewitz D; Craig TJ; Kiessling PC; Keinecke HO; Bernstein JA
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):62-8. PubMed ID: 21195947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema.
    Ohsawa I; Nagamachi S; Suzuki H; Honda D; Sato N; Ohi H; Horikoshi S; Tomino Y
    BMC Gastroenterol; 2013 Aug; 13():123. PubMed ID: 23915279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
    Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
    N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits.
    Bygum A; Andersen KE; Mikkelsen CS
    Eur J Dermatol; 2009; 19(2):147-51. PubMed ID: 19264579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National audit of a hereditary and acquired angioedema cohort in New Zealand.
    Lindsay K; Chua I; Jordan A; Stephens S
    Intern Med J; 2022 Dec; 52(12):2124-2129. PubMed ID: 34346157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema.
    Ocak M; Nain E; Akarsu A; Sahiner UM; Sekerel BE; Soyer O
    Allergy Asthma Proc; 2021 Jul; 42(4):325-332. PubMed ID: 34187624
    [No Abstract]   [Full Text] [Related]  

  • 34. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
    Bewtra AK; Levy RJ; Jacobson KW; Wasserman RL; Machnig T; Craig TJ
    Allergy Asthma Proc; 2012; 33(5):427-31. PubMed ID: 23026185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life with hereditary angioedema: then and now.
    Lane CJ; Grant JA; Dougherty D
    Postgrad Med; 2012 Jan; 124(1):144-51. PubMed ID: 22314124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary Angioedema Attacks: Local Swelling at Multiple Sites.
    Hofman ZL; Relan A; Hack CE
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):34-40. PubMed ID: 25527240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian physician survey on the medical management of hereditary angioedema.
    Fu L; Kanani A; Lacuesta G; Waserman S; Betschel S
    Ann Allergy Asthma Immunol; 2018 Nov; 121(5):598-603. PubMed ID: 29958877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrate.
    Shapiro RS; Zacek L
    J Infus Nurs; 2014; 37(4):284-90. PubMed ID: 24983261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angio-oedema due to hereditary C1 inhibitor deficiency in children.
    Caballero T
    Allergol Immunopathol (Madr); 2013; 41(1):45-53. PubMed ID: 22417938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.